G. Steger
- Internal Medicine top 5%
- Oncology top 5%
- Cancer Treatment and Pharmacology 23
- HER2/EGFR in Cancer Research 10
- Colorectal Cancer Treatments and Studies 8
- Bone health and treatments 5
- Cancer Diagnosis and Treatment 4
- Cancer Research top 10%
- Breast Cancer Treatment Studies 15
- Emergency Medical Services top 5%
- Hematology top 10%
-
- Advanced Breast Cancer Therapies 11
-
- Radiopharmaceutical Chemistry and Applications 5
G. Steger
52 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Internal Medicine 135
- Oncology 721
- Cancer Research 271
- Emergency Medical Services 121
- Hematology 148
Countries citing papers authored by G. Steger
This map shows the geographic impact of G. Steger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Steger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Steger more than expected).
Fields of papers citing papers by G. Steger
This network shows the impact of papers produced by G. Steger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Steger. The network helps show where G. Steger may publish in the future.
Co-authorship network
The 25 scholars most cited alongside G. Steger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 2 | |
| 2 | 2011 | 60 | |
| 3 | 2010 | 23 | |
| 4 | 2009 | 78 | |
| 5 | 2009 | 14 | |
| 6 | 2005 | 159 | |
| 7 | 2003 | 67 | |
| 8 | 2003 | 119 | |
| 9 | 2003 | 35 | |
| 10 | 2003 | 45 | |
| 11 | 2002 | 9 | |
| 12 | 2002 | 3 | |
| 13 | 2001 | 51 | |
| 14 | Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer. | 2000 | 34 |
| 15 | 2000 | 75 | |
| 16 | 1996 | 3 | |
| 17 | Complete remission of metastasisted clear cell sarcoma of tendons and aponeuroses | 1991 | 20 |
| 18 | 1988 | 28 | |
| 19 | 1988 | 21 | |
| 20 | Bovine tuberculosis at cattle shows. | 1970 | 1 |
About G. Steger
G. Steger is a scholar working on Oncology, Cancer Research, Pulmonary and Respiratory Medicine, Dermatology and Radiology, Nuclear Medicine and Imaging, having authored 54 papers that have together received 1.2k indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (23 papers), Breast Cancer Treatment Studies (15 papers), Advanced Breast Cancer Therapies (11 papers), HER2/EGFR in Cancer Research (10 papers), Colorectal Cancer Treatments and Studies (8 papers), Radiopharmaceutical Chemistry and Applications (5 papers), Bone health and treatments (5 papers) and Cancer Diagnosis and Treatment (4 papers). The work is most often cited by research in Internal Medicine (135 citations), Oncology (721 citations), Cancer Research (271 citations), Emergency Medical Services (121 citations) and Hematology (148 citations). G. Steger has collaborated with scholars based in Austria, Germany and Greece. Frequent co-authors include Robert M. Mader, Christoph Zielinski, Luc Dirix, Xavier Pivot, Nadia Harbeck, Gilles Romieu, David Miles, Javier Cortés, Piotr Tomczak and C Wiltschke. Their work appears in journals such as Journal of Clinical Oncology, European Journal of Cancer, British Journal of Cancer, Cancer Research and The Breast.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.